Ensemble, améliorons la qualité en santé

Home > English

Search

There are 1,134 results - Search

Sort by: Relevance - Title - Date - Type

Mask summuries

< [1] 2 3 4 5 ... >
1. ''Full care cycles'' HAS Expert Seminar, 15th-16th December 2011 - Paris
Page Web  - Online on 19/1/2012
2. HAS Expert Seminar Full care cycles_session_2_1_ALeperreDesplanques

Pathways' evaluation HAS Concept

530.16 Ko -  Online on 18/1/2012
3. MRI-guided vacuum-assisted breast biopsy (VABB)

MRI-guided VABB is a breast biopsy technique used for percutaneous histologic tissue acquisition of non palpable breast lesions, only detected by MRI and having neither sonographic nor mammographic correlates. This minimally invasive needle biopsy technique reduces the need for open surgical breast biopsy in patients with benign lesions and allows for optimal preoperative work-up and surgical planning through definitive diagnosis in patients with breast cancer. Our objective was to evaluate technical success rate, safety and diagnostic effectiveness of MRI-guided VABB and determine its clinical indications for use. Specific practice and facility requirements for reimbursement in France were equally assessed

Health technology assessment  - Online on 21/12/2011
4. Alzheimer's disease and related conditions - Diagnosis and treatment

To standardise practices relating to the diagnosis and treatment (drug and non-drug interventions, follow-up) of patients suffering from Alzheimer's disease or a related condition

Practice guidelines  - Online on 16/12/2011
5. AVAXIM ADULTES - CT 8198 - English version
56.01 Ko -  Online on 9/11/2011
6. AVAXIM PEDIATRIQUE - CT 7771 - English version
77.02 Ko -  Online on 9/11/2011
7. HAVRIX ADULTES - CT 8197 - English version
73 Ko -  Online on 4/11/2011
8. HAVRIX NOURRISSONS ET ENFANTS - CT 7591 - English version
87.74 Ko -  Online on 4/11/2011
9. Impact and results of quality improvement and patient safety programmes in hospitals : HAS studies and projects
Page Web  - Online on 12/10/2011
10. IMGENI study : Summary in English
772.39 Ko -  Online on 5/10/2011
11. Matrix Insight®: Summary in English
1.15 Mo -  Online on 5/10/2011
12. MOVIPREP - CT 6888 - English version
67.35 Ko -  Online on 16/9/2011
13. MOVIPREP
Date 23/9/2009
Inclusion on the list of medicines reimbursed by National Insurance and on the list of medicines approved for use by hospitals.
Opinions on drugs  - Online on 16/9/2011
14. ALTEISDUO - CT 8132 - English version
61 Ko -  Online on 8/9/2011
15. RANEXA - CT 6981 - English version
65.48 Ko -  Online on 8/9/2011
16. XILANIK - CT 7738 - English version
38.87 Ko -  Online on 18/8/2011
17. VELMETIA - CT 6479 - English version
98.37 Ko -  Online on 18/8/2011
18. ANGIOX - CT 7823 - English version
120.1 Ko -  Online on 18/8/2011
19. ONYTEC - CT 7347 - English version
89.87 Ko -  Online on 13/7/2011
20. TOCTINO - CT 6204 - English version
98.46 Ko -  Online on 13/7/2011
21. VIDAZA - CT 6362 - English version
78.37 Ko -  Online on 13/7/2011
22. ARIDOL - CT 7977 - English version
88.66 Ko -  Online on 13/7/2011
23. ARIDOL
Date 16/6/2010
Inclusion on the list of medicines approved for hospital use.
Opinions on drugs  - Online on 16/6/2011
24. Selection of iron metabolism tests in cases where iron deficiency is suspected

The French health insurance agency asked the HAS to determine strategies for the use of iron metabolism markers. In fact, the volume of procedures carried out in relation to all such tests which are reimbursed by the health insurance agency increased by 109% between 2000 and 2008. Furthermore, some tests appear to be redundant or irrelevant according to the latest French recommendations, (ANDEM, 1995). In this assessment, the HAS has focused on iron deficiency and has not looked at iron overloads, since professional recommendations issued by the HAS in 2005 on haemochromatosis still appear to be valid

Health technology assessment  - Online on 14/6/2011
25. PREZISTA - CT 7149-7150 - English version
96.73 Ko -  Online on 9/6/2011
26. MODIGRAF - CT 7077 - English version
71.89 Ko -  Online on 9/6/2011
27. PREZISTA
Date 2/12/2009
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for use by hospitals.
Opinions on drugs  - Online on 9/6/2011
28. NEISVAC - CT 7129 - English version
51.87 Ko -  Online on 6/6/2011
29. SUBCUVIA - CT 6963 - English version
61.41 Ko -  Online on 6/6/2011
30. EVICEL - CT 6940 - English version
67.19 Ko -  Online on 6/6/2011
31. VIMPAT - CT 6048 - English version
75.45 Ko -  Online on 6/6/2011
32. PROXALYOC - CT 6027 - English version
126.17 Ko -  Online on 6/6/2011
33. SUBCUVIA
Date 21/10/2009
Inclusion on the list of medicines approved for use by hospitals in the indication extension: “Replacement therapy for primary immunodeficiencies in children.”
Opinions on drugs  - Online on 6/6/2011
34. PROXALYOC
Date 1/4/2009
Reassessment of the actual benefit of piroxicam-based proprietary medicinal products for systemic use under article R.163-21 of the Social Security Code. This reassessment follows the EMEA arbitration procedure on piroxicam-based proprietary medicinal products.
Opinions on drugs  - Online on 6/6/2011
35. VIMPAT
Date 4/3/2009
Inclusion on the list of medicines reimbursed by National Health Insurance (apart from boxes of 168 and the solution for infusion) and approved for hospital use.
Opinions on drugs  - Online on 6/6/2011
36. EVICEL
Date 4/11/2009
Inclusion on the list of medicines approved for use by hospitals.
Opinions on drugs  - Online on 6/6/2011
37. NEISVAC
Date 21/10/2009
Inclusion on the list of products reimbursed by National Insurance for the new population recommended by the HCSP
Opinions on drugs  - Online on 6/6/2011
38. ALDARA - CT 7369 - English version
102.6 Ko -  Online on 30/5/2011
39. MENJUGATEKIT - CT 7081 - English version
42.17 Ko -  Online on 30/5/2011
40. HUMIRA - CT 7304 - English version
182.56 Ko -  Online on 30/5/2011
41. PLASMAVOLUME - CT 6338 - English version
40.35 Ko -  Online on 30/5/2011
42. EUCREAS - CT 5439 - English version
91.53 Ko -  Online on 30/5/2011
43. PLASMAVOLUME
Date 13/5/2009
Inclusion on list of products for hospital use.
Opinions on drugs  - Online on 30/5/2011
44. EUCREAS
Date 29/4/2009
Inclusion on the list of medicines reimbursed by National Health Insurance (box of 60) and approved for use by hospitals (boxes of 60 and 180).
Opinions on drugs  - Online on 30/5/2011
45. HUMIRA
Date 5/5/2010
Renewal of inclusion on the list of medicines reimbursed by National Health Insurance (+ request for reassessment of the wording of the improvement in actual benefit (IAB) in psoriasis, following the submission of new data).
Opinions on drugs  - Online on 30/5/2011
46. ALDARA
Date 10/3/2010
Renewal of inclusion on the list of medicines reimbursed by National Health Insurance.
Opinions on drugs  - Online on 30/5/2011
47. MENJUGATEKIT
Date 21/10/2009
Inclusion on the list of products reimbursed by National Insurance for the new population recommended by the High Council for Public Health: systematic vaccination for all infants aged 12 to 24 months and systematic catch-up vaccination up to and including the age of 24 years during the introduction of this new strategy and pending its optimal impact through group immunity.
Opinions on drugs  - Online on 30/5/2011
48. Health professionals programmes AMI Concept : Diagram

Programme AMI Alzheimer Health professionals programmes AMI Concept : Diagram

71.42 Ko -  Online on 26/5/2011
49. Abstract nr 282 : reducing the iatrogenicity of neuroleptics in patients with AD

Symposium HAS - BMJ : Clinical impact of quality improvement - Nice, April 19, 2010 Abstract nr 282 : Reducing the iatrogenicity of neuroleptics in patients with Alzheimer’s disease

109.9 Ko -  Online on 26/5/2011
50. RISPERDALCONSTA LP - CT 7257 - English version
73.72 Ko -  Online on 24/5/2011
< [1] 2 3 4 5 ... >

Tools

Refine by topic

Medical equipement (8) - Biotherapies, transfusions, transplantations (7) - Therapeutic patient education (2) - Interventional imaging (5) - Nutrition, dietetics (5) - Anaesthesia, sedation, analgesia (1) - Cardiac surgery (14) - Gastrointestinal surgery (8) - Oromaxillofacial surgery (4) - Ophtalmologic surgery (2) - Orthopaedic surgery (11) - Otorhinolaryngologic surgery (2) - Plastic surgery (2) - Urogenital surgery (2) - Vascular surgery (15) - Neurosurgery (6) - Operative surgical procedures (1) - Radiotherapy and physical agents (8) - Rehabilitation techniques (19) - Cell and tissue pathology (5) - Biology (laboratory tests) (14) - Medical imaging (27) - Alternative medicine (1) - Emergency treatment and intensive care (8) - Drug therapy (323) Cancers (61) - Digestive system cancers (12) - Genital cancers (10) - Respiratory tract cancers (7) - Urologic cancers (5) - Skin and connective tissue cancers (8) - Hematologic cancers (6) - Breast cancers (12) - Nervous system cancers (1) - Pain (7) - Disability (1) - Dental and mouth diseases (6) - Mouth diseases (1) - Jaw diseases (1) - Tooth diseases (4) - Heart diseases (28) - Myocardial ischemia (7) - Heart failure (4) - Cardiac arrhythmia (4) - Heart valves diseases (1) - Digestive system diseases (31) - Liver diseases (17) - Esophageal and gastrointestinal diseases (12) - Genital diseases (10) - Female genital diseases (8) - Male genital diseases (1) - Musculoskeletal diseases (35) - Joint and rheumatic diseases (28) - Muscular diseases (1) - Bone and cartilage diseases (5) - Respiratory tract diseases (15) - Bronchial diseases (7) - Pulmonary and pleural diseases (6) - Respiration disorders (3) - Eye diseases (10) - Skin and connective tissue diseases (16) - Blood and lymphatic diseases (10) - Bone marrow diseases (1) - Lymphatic diseases (1) - Blood coagulation and hemostasis disorders (7) - Allergy (3) - Immunologic deficiency syndromes (13) - Autoimmune diseases (17) - Demyelinating diseases (1) - Central nervous system diseases (18) - Neurodegenerative diseases (7) - Neuromuscular diseases (2) - Diabetes mellitus (9) - Endocrine system diseases (7) - Metabolic diseases (7) - Obesity (3) - Congenital, genetic and rare diseases (17) - Bacterial infections (16) - Parasitic diseases and mycoses (3) - Virus diseases (30) - Sexually transmitted diseases (19) - Ear diseases (3) - Nose and sinus diseases (3) - Phayngeal diseases (1) - Urethral diseases (1) - Kidney diseases (9) - Urination disorders (6) - Vascular diseases (35) - Aneurysm and other vascular malformations (3) - Embolism, thrombosis and stenosis (10) - Hypertension (8) - Peripheral vascular diseases (1) - Cerebrovascular disorders (5) - Alzheimer’s disease and mental disorders (1) - Depression and mood disorders (1) - Schizophrenia and delusional disorders (2) - Substance-related disorders (2) - Eating and sleep disorders (2) - Anxiety and neurotic disorders (2) - Disorders of psychological development (2) Accreditation of healthcare organisations (2) - Screening, prevention (36) - Health economics (78) - Legal expertise (1) - Patients’ records (1) - Patient information and patients’ rights (10) - Organisation of care (11) - Quality of care and patient safety (7) - Occupational health (1) - Pharmaceutical representative (1)

Refine by content type
Haute Autorité de Santé - 2009